Furthermore, resveratrol has been shown to effectively downregulate TGF-β expression in bronchoalveolar lavage fluid (BALF) in mice models of COPD and bleomycin-induced lung fibrosis (90, 91). This evidence concerns the gene TGFB1 and pulmonary fibrosis.